1. Home
  2. IBIO

IBIO

iBio Inc.

Logo iBio Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-17-2024 12:23pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

iBio Inc is a part of the healthcare sector. Its main business is commercialized technologies and product candidates and manufacturing services to clients and collaborators. Its main area of business is plant-based protein expression technologies for vaccines and therapeutic proteins and developing and commercializing select biopharmaceutical product candidates. Its products are used to combat various areas such as fibrotic diseases, cancers, and infectious diseases. The company operates in two segments: Biopharmaceuticals and Bioprocessing activities, conducted within iBio, Inc. and CDMO segment, conducted within iBio CDMO.

Founded: N/A Country:
United States
United States
Employees: N/A City: NEW YORK
Market Cap: 16.9M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 3.9M
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -15.02 EPS Growth: N/A
52 Week Low/High: $1.02 - $28.20 Next Earning Date: 05-13-2024
Revenue: $50,000 Revenue Growth: -97.22%
Revenue Growth (this year): N/A Revenue Growth (next year): 150.00%

Share on Social Networks: